Home > Publications database > PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group > print

001     1024594
005     20250804115153.0
024 7 _ |a 10.1016/S1470-2045(23)00525-9
|2 doi
024 7 _ |a 1470-2045
|2 ISSN
024 7 _ |a 1474-5488
|2 ISSN
024 7 _ |a 38181810
|2 pmid
024 7 _ |a WOS:001157190300001
|2 WOS
037 _ _ |a FZJ-2024-02268
082 _ _ |a 610
100 1 _ |a Albert, Nathalie L
|0 0000-0003-0953-7624
|b 0
245 _ _ |a PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
260 _ _ |a London
|c 2024
|b The Lancet Publ. Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1738146903_7913
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Response Assessment in Neuro-Oncology (RANO) response criteria have been established and were updated in 2023 for MRI-based response evaluation of diffuse gliomas in clinical trials. In addition, PET-based imaging with amino acid tracers is increasingly considered for disease monitoring in both clinical practice and clinical trials. So far, a standardised framework defining timepoints for baseline and follow-up investigations and response evaluation criteria for PET imaging of diffuse gliomas has not been established. Therefore, in this Policy Review, we propose a set of criteria for response assessment based on amino acid PET imaging in clinical trials enrolling participants with diffuse gliomas as defined in the 2021 WHO classification of tumours of the central nervous system. These proposed PET RANO criteria provide a conceptual framework that facilitates the structured implementation of PET imaging into clinical research and, ultimately, clinical routine. To this end, the PET RANO 1.0 criteria are intended to encourage specific investigations of amino acid PET imaging of gliomas
536 _ _ |a 5252 - Brain Dysfunction and Plasticity (POF4-525)
|0 G:(DE-HGF)POF4-5252
|c POF4-525
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Galldiks, Norbert
|0 P:(DE-Juel1)143792
|b 1
700 1 _ |a Ellingson, Benjamin M
|0 0000-0002-2764-6640
|b 2
700 1 _ |a van den Bent, Martin J
|0 0000-0001-5710-5127
|b 3
700 1 _ |a Chang, Susan M
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Cicone, Francesco
|0 0000-0003-4664-1965
|b 5
700 1 _ |a de Groot, John
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Koh, Eng-Siew
|0 0000-0002-1664-2513
|b 7
700 1 _ |a Law, Ian
|0 0000-0001-9644-7496
|b 8
700 1 _ |a Le Rhun, Emilie
|0 0000-0002-9408-3278
|b 9
700 1 _ |a Mair, Maximilian J
|0 0000-0002-6537-3874
|b 10
700 1 _ |a Minniti, Giuseppe
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Rudà, Roberta
|0 0000-0001-9134-1537
|b 12
700 1 _ |a Scott, Andrew M
|0 0000-0002-6656-295X
|b 13
700 1 _ |a Short, Susan C
|0 0000-0003-4423-7256
|b 14
700 1 _ |a Smits, Marion
|0 0000-0001-5563-2871
|b 15
700 1 _ |a Suchorska, Bogdana
|0 0000-0002-1083-8232
|b 16
700 1 _ |a Tolboom, Nelleke
|0 0000-0002-8005-2833
|b 17
700 1 _ |a Traub-Weidinger, Tatjana
|0 0000-0003-1118-926X
|b 18
700 1 _ |a Tonn, Joerg-Christian
|0 0009-0004-1756-423X
|b 19
700 1 _ |a Verger, Antoine
|0 P:(DE-Juel1)171957
|b 20
700 1 _ |a Weller, Michael
|0 0000-0002-1748-174X
|b 21
700 1 _ |a Wen, Patrick Y
|0 0000-0002-0774-7700
|b 22
700 1 _ |a Preusser, Matthias
|0 0000-0003-3541-2315
|b 23
773 _ _ |a 10.1016/S1470-2045(23)00525-9
|g Vol. 25, no. 1, p. e29 - e41
|0 PERI:(DE-600)2035574-9
|n 1
|p e29 - e41
|t The lancet / Oncology
|v 25
|y 2024
|x 1470-2045
856 4 _ |u https://juser.fz-juelich.de/record/1024594/files/post-print.pdf
|y Restricted
909 C O |o oai:juser.fz-juelich.de:1024594
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)143792
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5252
|x 0
914 1 _ |y 2024
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-17
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b LANCET ONCOL : 2022
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-17
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-17
915 _ _ |a IF >= 50
|0 StatID:(DE-HGF)9950
|2 StatID
|b LANCET ONCOL : 2022
|d 2024-12-17
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21